Hepatic Steatosis Clinical Trial
Official title:
Effect of β-nicotinamide Mononucleotide Intervention on Healthy Young Subjects With Acute Binge Drink: a Double-blinded, Randomized, Crossover Trial
The goal of this double-blinded, randomized, crossover trial is to investigate the effects of NMN supplementation on liver function, liver fat content and lipid metabolism in healthy young subjects with acute binge drink. The main questions it aims to answer are: 1. if NMN administration could accelerate alcohol metabolism and alleviate hangover symptom; 2. if NMN administration could alleviate alcohol-induced liver injury and hepatic steatosis.
The goal of this double-blinded, randomized, crossover trial is to investigate the effects of NMN supplementation on liver function, liver fat content and lipid metabolism in healthy young subjects with acute binge drink. The main questions it aims to answer are: 1. if NMN administration could accelerate alcohol metabolism and alleviate hangover symptom; 2. if NMN administration could alleviate alcohol-induced liver injury and hepatic steatosis. Participants will be randomized into two groups (n=20), and take 4 NMN capsules (250mg/capsule) or 4 placebo capsules (maltodextrin), respectively. 15 minutes later, they are successively provided with same breakfast and then vodka with a dose of 1g/kg body weight. Venous blood are collected at 0h, 1h, 2h, 3h, 4h, 8h, 12h and 24h from each subject, respectively. In addition, nuclear magnetic resonance imaging (MRI) are taken at 0h, 4h and 24h after alcohol intake. After a 7-day washout period, volunteers are crossed over to another alternative group to receive the corresponding capsules and the test protocol repeats twice. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05480696 -
Soluble Fibre Supplementation in NAFLD
|
Phase 1 | |
| Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A | |
| Recruiting |
NCT05499585 -
Treating Pediatric NAFLD With Nutrition
|
N/A | |
| Completed |
NCT03717935 -
Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS
|
N/A | |
| Active, not recruiting |
NCT02493153 -
Hepatic Steatosis After Cholecystectomy
|
N/A | |
| Active, not recruiting |
NCT05654051 -
The SLIM LIVER Study
|
Phase 2 | |
| Completed |
NCT03334214 -
Safety, Tolerability, and Pharmacodynamics of IONIS-DGAT2Rx in Adult Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT05599945 -
First Human Dose Trial for a New Medication to Potentially Treat Liver Diseases
|
Phase 1 | |
| Enrolling by invitation |
NCT02816814 -
Lacto-ovo-vegetarian Diet Riched in Omega-3 Fatty Acids in Menopausal Women
|
N/A | |
| Active, not recruiting |
NCT03587727 -
Hepatic Mitochondrial Function in Youth
|
||
| Not yet recruiting |
NCT06394206 -
Benefit of a Hospital Intervention in Patients With Hepatic Steatosis
|
N/A | |
| Not yet recruiting |
NCT05935826 -
Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
|
N/A | |
| Not yet recruiting |
NCT06363617 -
Implementation of the Fatty Liver Index in Primary Care
|
N/A | |
| Recruiting |
NCT03142698 -
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
|
N/A | |
| Completed |
NCT00480922 -
Effects of a Low Glycemic Load Diet on Fatty Liver in Children
|
N/A | |
| Not yet recruiting |
NCT05871749 -
Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis B
|
||
| Recruiting |
NCT05897073 -
Time-Restricted Eating, Exercise and Cardiometabolic Health in Obesity
|
N/A | |
| Completed |
NCT03961516 -
Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis
|
||
| Completed |
NCT04180631 -
Quantitative US for Hepatic Steatosis
|
N/A | |
| Terminated |
NCT00845845 -
Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
|
Phase 2 |